patient's problem," Byrnes said. One of his conclusions was obvious but necessary: it does not save time to disrupt the patient's opening statement nor to stop him talking, for it may prevent his real problems from coming to the surface.
If such miscommunication and misunderstandings frequently exist, it is not surprising that the outcome of careparticularly as perceived by patients-should be adversely affected. This is well documented in Dr. Starfield's present study.' As the authors state, their findings suggest several areas for further investigation.
Analyses of interviewing skills by audio and video tapes are already being used in teaching situations. 6 7 In spite of the obvious ethical problems, it has been demonstrated that such recordings are acceptable by both when informed consent is given by both patients and practitioners. The taped interview may be only a fragment of a continuing patient/ practitioner relationship, but it can generate useful discussion for both participants. If reviewing such recordings results in better communications with that individual patient, much has been gained. Facilities for making such recordings are now readily available and, with appropriate precautions, even practitioners with considerable years of experience can learn from them.* It is important that one not lose sight of the goal: improved outcome of patient care from the patient's viewpoint. Apart from the need for more research and investigation as well as better teaching, those who are currently engaged in providing health care need to be ever watchful and strive to improve their own standards for communication. To achieve this, there are some questions they can ask themselves: * No matter how experienced a practitioner I am, can I afford to leave a patient wondering whether I have really understood his or her complaint? * Have I really listened? Or have I too quickly jumped to my own conclusions? * Have I given the patient the opportunity to give me feedback? * Have I found the underlying cause rather than the surface problem? * Above all, have I given the impression that I am there to meet the patient's need, and have I demonstrated not only a willingness but an ability to care? * What about sharing my written records with my patients? This last would certainly be a positive demonstration of willingness to share responsibility for health care with the patient, and give me an opportunity to hear whether my impressions of the interaction are really shared by the patient. 8 The issue is not just improved communication with patients per se or patient satisfaction. The outcomes of diagnosis and treatment depend upon unimpaired communication between patient and practitioner.9' 10
Environmental Contamination of Human Breast Milk
In the current issue of the Journal, studies of breast milk of nursing mothers in Michigan illustrate the ubiquity and magnitude of human contamination with polychlorinated biphenyls (PCBs). I It is important to note that the Michigan population studied was also rather thoroughly exposed to polybrominated biphenyls (PBBs).2 Tests of serum and apidose tissue of the same population have also revealed that there is virtually universal contamination with DDE, a metabolite of the pesticide DDT.3 Probably, the only unique feature of the Michigan population is the presence of PBB; in regard to PCB and DDE, the Michigan population appears to be similar to other populations that have been studied.4'5
By measuring the level of contamination in human milk, Wickizer, et al, I have again raised questions about possible risks from breast-feeding. The fact of contamination is known by a considerable number of people, many of whom express concern over the safety of breast milk. As knowledge of breast milk contamination spreads, we will be increasingly faced with questions about the safety of breastfeeding. Our problem is to know how to answer such questions. An additional question arises with regard to mothers who are currently unaware of, or not worried by, breast milk contamination-should we draw their attention to the potential risk of breast-feeding?
What causes concern is our knowledge that the polyhalogenated biphenyls (PHBs) are toxic in various animal test systems and, at least in high doses, in humans. Among the established effects of PHBs are hepatic dysfunction, der-matopathology, neurological and behavioral abnormalities, immunological aberrations, thyroid dysfunction, gastrointestinal disturbances, reproductive dysfunction, tumorigenesis, and enzyme induction.6-8 This list suggests the potential for trouble and the many measures that may be necessary to determine the presence or absence of toxicity. An additional worry for which there also is no answer is the possibility of additive effects of halogenated hydrocarbon burden, i.e., PBB + PCB + DDE, etc. So far there are no obvious indications of toxicity from the halogenated hydrocarbon levels that are commonly encountered in nonoccupationally exposed people in the United States. However, we cannot be sure about subtle or long-range adverse effects of PHB contamination.
The problem is compounded by the fact that PCBs and PBBs, although apparently similar in some respects, have different toxicities, certainly quantitatively and probably qualitatively.7'8 In addition, PHBs are not pure chemicals, but rather mixtures of isomers and congeners, each presumably with its quantitative and qualitative toxicity proffle. As if that were not enough, there is the additional presence of incidental contaminants, such as dibenzofurans, dioxins, etc., each with its own toxic properties. We are only beginning to understand the relative toxicities of these components, and there is, as of now, little information about the effect of passage through the biological food chain on the relative concentration of these components.
The question of whether or not there is a threshold or dose-response effect of PHB toxicity is unanswered. The animal data and the limited human data are confusing on this issue.6-8 The confusion is due not only to variable results between studies, but also to variable results within studies. On the whole, most studies have failed to offer clear evidence of a dose-response relationship. This indicates a pitfall in the investigation of toxicity. Objective measures of function have generally failed to show a dose-response relationship, while analyses of more subjective variables (symptoms) or variables affected by emotional state (performance on neurobehavioral tests) generally show no correlation or an inverse correlation with PHB levels.9-'0 However, other studies in animal systems raise such concern about toxicity and at doses that might be encountered in man" that few investigators have been willing to say that endemic levels of PHBs are not toxic in man.
It seems reasonable to assume that there will be variability in who shows evidence of toxicity and how such toxicity will manifest itself. In the Michigan PBB experience, the strong intrafamily correlations of reported symptoms and of PBB levels appear to be controlled by environmental factors.9 12 However, genetic control of some of the variation and correlation has not been excluded. PHBs are stored in fat. Several studies have calculated the partitioning ratios among fat, serum, and breast milk. [1] [2] Whether or not these ratios apply to all constituents of the PHB mixture is unknown. What is known is that partitioning varies between individuals, and even within an individual.2 Some of this variation may be correlated with absolute body burden and some with percentage of body fat, but other unexplained variables are also apparent. What effect this variability might have on the expression of toxicity is unknown. It must also be recognized, in the context of the breast-feeding issue, that PHBs cross the placenta and can readily be found in fetal tissues.'I Thus each infant who will be exposed to PHB-contaminated breast milk already has a transplacentally acquired some body burden of PHBs. Of particular concern is the fact that, in contradistinction to the adult, PHBs are found in the fetal brain (Barr, unpublished data) .
We also need to know if we can modify the potential risks of PHB contamination. Since PHBs are largely stored in fat, we could alter the concentration in the body by varying the amount of adipose tissue. There are worries that rapid mobilization of PHBs from fat stores could lead to acute toxicity by increasing serum levels. It has also been observed that parturition-lactation may be accompanied by increased mobilization of PHBs from fat depots.'3 Other than by lactation, we have no known ways of speeding the excretion or metabolism of PHBs. At present, it seems that the only advice we can offer is to avoid adding more consumed PHBs to the body burden.
In the face of all this ignorance, we are nonetheless asked by mothers whether or not they should breast-feed their babies. There is no simple answer to this question. It is an area in which passions may prevail over admittedly weak science. Over and above questions of toxicity, consideration must be given to the adverse effects of anxiety about breast milk contamination on the mother-infant pair. Denying that a problem may exist can, in many cases, lead to increased anxiety. Reassurance should help reduce anxiety, but how can one say "I don't know" and sound reassuring?
Human breast milk is decidedly the preferred food for human infants and breast-feeding is the preferred method of feeding. On the other hand, it should be recognized that formula-feeding by bottle is widely accepted as an alternative with apparent safety and good results in the majority of cases. There are circumstances in which formula-feeding may be necessary or even desirable. The question is, does PHB contamination of breast milk constitute a reason to discourage breast-feeding? Kendrick asserts that the argument is between the known benefits of breast-feeding and the potential risk of PHB contamination.14 Since transplacental PHB contamination has already taken place, another perspective is that we should weigh the potential risks of formula-feeding against the potential risks of adding to PHB contamination.
Before any recommendations can be made, there must be knowledge of contaminant levels in the mother's adipose tissue or breast milk. Testing of all mothers is not advocated. Mothers should be questioned, however, about direct and indirect exposures to PCBs, PBBs, insecticides, etc., and about dietary exposures to the same compounds (e.g., PCBs and fish from contaminated waters, PBBs and milk/meat/ eggs from contaminated farms). If exposure is ascertained or deemed likely, then testing adipose tissue or breast milk can be advised.
In the current situation we can opt for one of two extremes or choose some spot on the middle ground. It has been advised that mothers with burdens of PHBs or other environmental contaminants not breast-feed at all. This certainly would avoid adding to the body burden of the infant who has already been transplacentally exposed. However, such advice, if taken, would mean that few mothers would breast-feed their infants since virtually all mothers have contaminants in their milk, many at levels above those permitted by law in other foodstuffs.
The other extreme is to recommend that mothers breastfeed until such time as it can be demonstrated that harm results. This argument boils down to a statement that we are prepared to deal only with proven damage and consideration of preventive measures is premature.
Middle-ground proponents try to reconcile the desirability of breast-feeding with the desire to steer clear of damaging babies. Advice in this area can come in two forms: refrain from breast-feeding if PHB levels in the milk are high, or limit the duration of breast-feeding. The latter is proposed as a means of reducing the added exposure, while obtaining at least some of the benefits of breast-feeding.
Since we lack evidence of PHB dose-response relationships, we will have to rely on other criteria for defining highmedium-low levels of each of the contaminants. The most readily available method would be to arbitrarily correlate our level of concern with levels of contamination found in the population (e.g., the top 10 per cent is "high".) On such a basis, mothers with very high levels could be advised to refrain from breast-feeding; mothers with high levels could be advised to limit the duration of breast-feeding, with the duration correlated with the PHB level. As further information is acquired on the toxicity or safety of these compounds, the recommended course of action could be suitably modified.
In summary, there are only fragmentary answers to some very important questions in this complex area. Until those answers are more complete, it is urged that consideration be given to limiting the further exposure to PHBs of infants of the most highly contaminated mothers in our population.
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